Press Room

Menu icon

MedShadow’s coverage and commentary highlight our mission to provide science-based information, independent of pharmaceutical influence, to help people to make informed decisions about the RX and OTC medications they take. For media inquiries, contact Lisa Jaycox at press@medshadow.org.

Recent News

Read recent coverage featuring MedShadow’s work and experts.

THE SHORTY AWARDS
Shorty Awards: Investigating Generics

MedShadow's Investigating Generics series of articles, webinars, and survey named as a finalist for its creativity and effectiveness.
read more
Pharmacoepidemiology & Drug Safety
Characteristics of U.S. FDA Drug Recalls Involving Opioid Medications, 2002-2025

This paper analyzes over 20 years of FDA recall data and credits Emma Yasinski and MedShadow for "thoughtful inquiries regarding opioid supply safety that inspired the conception of the manuscript."
By Julio Nunes read more
The Business of Content
How a small journalism nonprofit is holding the largest pharma companies to account

MedShadow's Diane Salvatore explains our nonprofit investigative journalism approach, success with social media videos, and what's on the horizon for MedShadow's advocacy and editorial priorities.
By Simon Owens read more
ADHD Wise Squirrels
ADHD Medication Quality, Oversight, and Reporting

MedShadow's Emma Yasinski explores the hidden complexities of medication safety, the ongoing ADHD medication shortage, and the vital role patients play in drug oversight.
By Dave Delaney read more
United Press International
Common painkillers cited as cause of misdiagnosed heart failure

Drugs like gabapentin can cause fluid retention, leading to symptoms that doctors may confuse for heart failure. MedShadow’s article on prescription cascades offers more information.
By Dennis Thompson read more
Those Nerdy Girls Blog
From Civil Rights Hubs to Pharmacy Deserts: What Pharmacy Closures Mean—And How You Can Take Action

Pharmacies provide essential care. The loss of a nearby pharmacy hurts the people who rely on it the most. An article in MedShadow’s Meet Me At the Medcart inspired this post.
By MacKenzie Isaac and Daphne Berryhill read more
The Street / Yahoo! Finance
US government issues recall for popular blood pressure medicine

Food and drug recalls are a fact of life. In this article, a MedShadow article is cited with an interviewee, Joey Mattingly, quoted about the drug recall process.
By Dana Sullivan Kilroy read more
Live Beyond the Norms Podcast
Episode 118: The Hidden Dangers in Your Medicine Cabinet

MedShadow’s Suzanne Robotti discusses drug trials, ADHD, and the importance of being your own health advocate.
By Chris Burres read more
The People's Pharmacy
Why Won’t MDs and Pharmacists Believe You When Generic Drugs Fail?

MedShadow’s webinar on Investigating Generic Drugs featured Joe Graedon, David Light, and Katherine Eban.
By Joe Graedon read more
Drug Patent Watch
The Definitive Guide to Generic Drug Approval in the U.S.: From ANDA to Market Dominance

MedShadow’s Investigating Generics coverage is cited in this comprehensive report on the generic drug market in the U.S.
By Yali Friedman, thinkBiotech read more
Stat
FDA Clinical Trial Inclusivity Guidelines Will Be Back

In this op-ed, MedShadow’s Suzanne Robotti argues that inclusivity guidelines at the FDA are “necessary.”
By Suzanne B. Robotti read more
association of healthcare journalism
A Sickle Cell Drug That Was Hyped In Headlines Is Now Suspected Of Harming Patients

MedShadow’s Suzanne Robotti is quoted and advises that neutral language should be used for new drugs, rather than boosterish language like “miracle” or “game-changer.”
By Mary Chris Jaklevic read more
Stat News
The FDA should withdraw approval of more than 400 tainted medicines

In this op-ed, MedShadow’s Suzanne Robotti argues that the FDA should have withdrawn 400 drugs from the market after learning they had received fraudulent testing data.
By Suzanne Robotti read more
National Center for Health Research
Open Letter to the FDA: You’re Protecting the Wrong People

An unnamed number of drugs on the market were approved based on potentially fraudulent testing and data. These medications may not be safe or effective, writes Suzanne Robotti.
By Suzanne Robotti read more
Ask a Patient Health News
Treatments for COPD, excessive sweating, and more

MedShadow Foundation’s article about the DEA’s schedule of drugs is cited in this round-up of drug and treatment news.
By Katie Rowley read more
Better Than a Pill Podcast
Episode 55: Interview with Suzanne Robotti

Ever wondered who's safeguarding you from medication risks? MedShadow’s Suzanne Robotti speaks about how she turned her own adversity into action.
By Movement Craft read more
Authority Magazine
Women In Wellness: Five Lifestyle Tweaks That Will Help Support People’s Journey Towards Better Wellbeing

From mental health to physical well-being, women like Su Robotti are making significant strides in bringing about change, introducing innovative solutions, and setting new standards.
By Wanda Malhotra read more
GET SAVVY: DEMYSTIFYING HEALTHCARE
Episode 56: Prescribed and Confused? Ask These 5 Key Medication Questions

Feeling powerless in the face of medication decisions? MedShadow’s Su Robotti's personal journey will surprise and inspire you.
By Sandy Kibling read more
Fathers After 50
Exploring the Hidden Dangers of Prescription Drugs. A Personal Odyssey of Side Effects and Alternative Treatments

Why are we swallowing so many drugs? Are they necessary? Are they safe? MedShadow’s Suzanne Robotti explores lesser-known stories behind medicines.
By Greg Patterson read more
Type 2 Diabetes Talk
17 Unspoken Truths About Prescription Medication

Discover the untold truths of medication safety with MedShadow’s Suzanne Robotti.
By Dr. Jedha read more
Authority Magazine
Becoming Pain-Free: How to Alleviate Chronic Pain

Pain can lead you to avoid movement, but almost any movement helps lower pain. MedShadow’s Suzanne Robotti shares insights to help those suffering from chronic pain.
By Maria Angelova read more
Med City News
An Attack on Patients’ Right to Informed Consent

In this op-ed, MedShadow’s Suzanne Robotti discusses claims that Merck failed to warn patients about the risk of an atypical femoral fracture from Fosamax.
By Suzanne Robotti read more
The Light of Life
The Trials and Errors of Prescription Drugs

MedShadow’s Suzanne Robotti shares her personal story and experiences living with the damaging side effects of DES.
By Naomi DeBello read more
Veganish and All Things Healthy
Episode 319: Su Robotti, Founder of MedShadow.org

MedShadow’s Suzanne Robotti discusses MedShadow Foundation’s mission and usefulness to people researching the side effects of medicines.
By Freya Magnusson read more
AARP
DES Daughters: A Medication My Mother Took Before I Was Born Will Affect Me for Life

MedShadow’s Suzanne Robotti shares her personal story about a drug that was given to millions of pregnant women with unintended side effects.
By Bobbi Dempsey read more
Politico
FDA advisers recommend the agency approve the first over-the-counter birth control pill

As a FDA Advisory Board Consumer member, MedShadow’s Suzanne Robotti weighs in on HRA Pharma’s Opill being approved for sale without a prescription.
By Katherine Ellen Foley read more